MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
10.22
+0.21 (2.14%)
At close: Nov 11, 2026, 4:00 PM EST
10.22
0.00 (-0.04%)
Pre-market: Nov 12, 2026, 6:35 AM EST
MiNK Therapeutics Market Cap
MiNK Therapeutics has a market cap or net worth of $52.17 million as of November 11, 2026. It is the 29,621st most valuable company in the world and the 4,545th biggest in the United States. Its market cap has decreased by 17.67% in one year.
Market Cap
52.17M
Enterprise Value
43.37M
1-Year Change
-17.67%
Global Rank
Country Rank
#4,545 United States
Category
ChartMarket Cap Chart
Since the IPO on October 15, 2021, MiNK Therapeutics's market cap has decreased from $386.36M to $52.17M, a decrease of -86.50%. That is a compound annual growth rate of -32.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 52.17M | -0.32% |
| Dec 31, 2025 | 52.34M | 89.51% |
| Dec 31, 2024 | 27.62M | -25.23% |
| Dec 29, 2023 | 36.94M | -58.11% |
| Dec 30, 2022 | 88.18M | -40.99% |
| Dec 31, 2021 | 149.43M | -61.32% |
| Oct 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Boundless Bio | 55.96M |
| Xilio Therapeutics | 55.73M |
| RenovoRx | 55.06M |
| iBio, Inc. | 53.00M |
| Annovis Bio | 52.92M |
| Eloxx Pharmaceuticals | 52.51M |
| Oncolytics Biotech | 52.48M |
| Rein Therapeutics | 52.28M |